Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab.

Jorge Soler Lopez,Ramon De Las Penas,Leticia De avila,María De Julián,María Arnal,Eduardo Martínez-de-Dueñas,Santiago Olmos,Ángela López Rodríguez,Javier Munarriz,Ana Peset,Alejandro Cortell,Candela Rodriguez,Angel Solloso

Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab.

2014

Jorge Soler Lopez
Ramon De Las Penas
Leticia De avila
María De Julián
María Arnal
Eduardo Martínez-de-Dueñas
Santiago Olmos
Ángela López Rodríguez
Javier Munarriz
Ana Peset
Alejandro Cortell
Candela Rodriguez
Angel Solloso

e20686 Background: To evaluate whether echocardiographic parameters and serum biomarkers may predict early cardiac dysfunction in patients treated with taxanes, anthracyclines with / without trastu...

Keywords:

Breast cancer
Trastuzumab
Pathology
Cancer research
Biomarker (medicine)
Cardiotoxicity
Medicine
Oncology
serum biomarkers
Internal medicine
prospective evaluation
cardiac dysfunction
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations